About: A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 January 2017

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2017 (ast) наукова стаття, опублікована в січні 2017 (uk) scientific article published on 31 January 2017 (en) مقالة علمية نشرت في 31 يناير 2017 (ar)
publication date	wds:Q37699709-D15BE4C7-281F-4A29-9EA4-BAAC092AC94A
publication date	2017-01-31 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37699709-609949F3-5020-4B8E-B4BC-DD989251DB76
language of work or name	English
exact match	wds:Q37699709-7CC993AF-A053-49E5-AF79-908AA64EE7C0
exact match	https://scigraph.springernature.com/pub.10.1007/s12325-017-0483-1
cites work	wds:Q37699709-028E93D6-1755-4166-BD1B-ACA71E83F619 wds:Q37699709-1AAA4D10-921E-4A06-BB40-B754419088C7 wds:Q37699709-2039BF4D-2738-4CF7-A6CF-D2D5F2DDF944 wds:Q37699709-4F1478E1-FBA8-44E0-879F-30176821DCF1 wds:Q37699709-5C790FEF-8068-403B-8872-1B5FDED5BB50 wds:Q37699709-72BA2D21-A849-4975-ADDB-D8D12E51387F wds:Q37699709-7C2BA424-E1AB-418E-ADE2-0DB54CF875F7 wds:Q37699709-802FE42D-2D98-4B0A-B99A-D746FC7EC4EF wds:Q37699709-818A13D7-7CFC-454C-A245-B38D29329610 wds:Q37699709-97997C4E-AFA7-486D-89DD-EE5C7D8115FA wds:Q37699709-AF24D3C1-3E5A-4FC0-B190-28CF5E172B1D wds:Q37699709-B48E6C3E-BA19-404B-80B4-340BBC6696EE wds:Q37699709-CD7EA447-7C62-4ADB-9CF7-0BA83A533BC4 wds:Q37699709-EC39947C-5714-42EF-B170-B468C149C2D2 wds:Q37699709-EF53E80B-C2F8-4C2C-AFF3-DA4DA705649C
cites work	Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort Guidelines for good pharmacoepidemiology practices (GPP). Prevalence of age-related macular degeneration in the United States The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting. TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV: Incidence of Blindness and Sight Impairment in Ranibizumab-Treated Patients. The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care. Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study. Ranibizumab according to need: a treatment for age-related macular degeneration Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
author name string	wds:Q37699709-1B6326A9-26FC-4402-AA41-FACB080FB6C4 wds:Q37699709-3FC5077F-123B-485C-964D-1024CDD3AEC7 wds:Q37699709-62FEB89E-62FC-476A-9CD7-E9D2709A76AB wds:Q37699709-9330A921-83B5-4715-9CC6-B3A846217E4C wds:Q37699709-D6985D09-05CA-43A3-B5DD-F794706ED64D
author name string	Alberto Ferreira Adrian Skelly Fran Milnes Hans-Joachim Carius Robert L Johnston
rdfs:label	A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nl) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (en) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (ast)
skos:prefLabel	A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nl) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (en) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (ast)
name	A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nl) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (en) A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (ast)
author	wds:Q37699709-B429F875-194E-4460-A97F-6C8DFE313011
author	Paul Mitchell
title	wds:Q37699709-6C53B72D-3C69-41AB-951E-D3D99FB0241B
title	A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom (en)
page(s)	wds:Q37699709-D3CA4661-57B0-49AC-BA00-AF56855716F8
page(s)	703-712
instance of	wds:Q37699709-F4D34926-C450-452D-B28A-CFD8CD17D12B
instance of	scholarly article
main subject	wds:Q37699709-0AE3A72B-034D-4684-84ED-318C10764E42 wds:Q37699709-E3B46FF0-5017-445B-901F-07C46AAFFA0A
main subject	Australia macular degeneration
PubMed ID	wds:Q37699709-1895C0CA-6910-44BE-9FEC-798978969146
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28144918
PubMed ID	28144918
published in	wds:Q37699709-C52432A0-66AC-431C-A843-B23C659F7763
published in	Advances in Therapy
issue	wds:Q37699709-E641D80E-1A9B-46AF-AC5C-953B82EFA02B
volume	wds:Q37699709-AA1ADAE1-F013-40E2-A99F-C7369EF9B6C1
issue	3
volume	34
DOI	wds:Q37699709-A18180D6-1B2E-48CA-B0B6-D1F775E74C88
DOI	http://dx.doi.org/10.1007/S12325-017-0483-1
DOI	10.1007/S12325-017-0483-1
copyright license	wds:Q37699709-842437ab-2ea4-4055-9f8b-4b3cc7372f06
copyright status	wds:Q37699709-1edf0717-40a6-42a4-8ffa-1f10e6e0848b
copyright license	Creative Commons Attribution 4.0 International
copyright status	copyrighted

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software